{
    "nctId": "NCT03389061",
    "officialTitle": "Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet",
    "inclusionCriteria": "1. Patients with SOF/VEL treatment for the treatment of chronic HCV genotype 1 through 6.\n2. Patient is at least 18 at the day of screening.\n3. Patient is able and willing to sign the Informed Consent Form.\n4. Patient is able and willing to follow protocol requirements.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "1. Pregnant female (as confirmed by an hCG urine test performed at screening) or breast-feeding female.\n2. Relevant history or current condition that might interfere with drug absorption, distribution, metabolism or excretion.\n3. Inability to understand the nature and extent of the study and the procedures required.\n4. Clinically relevant low hemoglobin concentration at screening judged by the patient's own hepatologist."
}